Azaquinazoline Inhibitors of Atypical Protein Kinase C
申请人:Cancer Research Technology Limited
公开号:US20160102094A1
公开(公告)日:2016-04-14
The present application provides a compound of formula (1)
or a salt thereof, wherein R
7
, R
8
, R
9
, G, and X are as defined herein. This application further describes compositions comprising the same. Compounds of formula (I) and their salts have aPKC inhibitory activity, and may be used to treat proliferative diseases.